RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice

Drug Metabolism and Disposition

Volumn 41, Issue 4, 2013, Pages 844-857

  Lu, Hong ^a   Gunewardena, Sumedha ^c   Cui, Julia Y ^b   Yoo, Byunggil ^c   Zhong, Xiao Bo ^d   Klaassen, Curtis D ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ACYLTRANSFERASE 8; CATECHOL METHYLTRANSFERASE; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6B; GLUCURONOSYLTRANSFERASE 2A3; GLUCURONOSYLTRANSFERASE 2B1; GLUCURONOSYLTRANSFERASE 2B36; GLUCURONOSYLTRANSFERASE 2B5; GLUCURONOSYLTRANSFERASE 3A1; GLUCURONOSYLTRANSFERASE 3A2; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE P2; GLUTATHIONE TRANSFERASE Z1; LIVER ENZYME; MESSENGER RNA; METHIONINE ADENOSYLTRANSFERASE; METHYLTRANSFERASE; NICOTINAMIDE METHYLTRANSFERASE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1C2; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT;

ACETYLATION; ADOLESCENT; ADULT ANIMAL; AMINO ACID CONJUGATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GLUCURONIDATION; GLUTATHIONE METABOLISM; HEPATIC ONTOGENY; KIDNEY; LIVER; MALE; METHYLATION; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RNA SEQUENCE; SMALL INTESTINE; SULFATION; TISSUE DISTRIBUTION;

AGING; ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTESTINE, SMALL; KIDNEY; LIVER; MALE; METABOLIC DETOXICATION, PHASE II; MICE; ORGAN SPECIFICITY; SEQUENCE ANALYSIS, RNA;

MUS;

EID: 84875838780     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.050211     Document Type: Article

References (51)

1. Aksoy S, Szumlanski CL, and Weinshilboum RM (1994) Human liver nicotinamide Nmethyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem 269:14835-14840.
2. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255.
3. Alnouti Y and Klaassen CD (2011) Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Xenobiotica 41:187-197.
4. Arakawa S, Maejima T, Kiyosawa N, Yamaguchi T, Shibaya Y, Aida Y, Kawai R, Fujimoto K, Manabe S, and Takasaki W (2010) Methemoglobinemia induced by 1,2-dichloro-4-nitrobenzene in mice with a disrupted glutathione S-transferase Mu 1 gene. Drug Metab Dispos 38:1545-1552.
5. Badenhorst CP, Jooste M, and van Dijk AA (2012) Enzymatic characterization and elucidation of the catalytic mechanism of a recombinant bovine glycine N-acyltransferase. Drug Metab Dispos 40:346-352.
6. Baik M, Yu JH, and Hennighausen L (2011) Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Ann N Y Acad Sci 1229:29-37.
7. Blake MJ, Castro L, Leeder JS, and Kearns GL (2005) Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123-138.
8. Bock KW (2010) Functions and transcriptional regulation of adult human hepatic UDPglucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 80:771-777.
9. Buckley DB and Klaassen CD (2009) Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney. Drug Metab Dispos 37:834-840.
10. Bushey RT, Dluzen DF, and Lazarus P (2013) Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism. Drug Metab Dispos 41:170-179.
11. Clayton PT (2011) Disorders of bile acid synthesis. J Inherit Metab Dis 34:593-604.
12. Cooper AJ and Pinto JT (2006) Cysteine S-conjugate beta-lyases. Amino Acids 30:1-15.
13. Cui JY, Choudhuri S, Knight TR, and Klaassen CD (2010) Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol Sci 116:32-43.
14. Cui JY, Gunewardena SS, Yoo B, Liu J, Renaud HJ, Lu H, Zhong XB, and Klaassen CD (2012) RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development. Toxicol Sci 127:592-608.
15. Doerge DR, Twaddle NC, Vanlandingham M, and Fisher JW (2011) Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys. Toxicol Lett 207:298-305.
16. Fujimoto K, Arakawa S, Watanabe T, Yasumo H, Ando Y, Takasaki W, Manabe S, Yamoto T, and Oda S (2007) Generation and functional characterization of mice with a disrupted glutathione S-transferase, theta 1 gene. Drug Metab Dispos 35:2196-2202.
17. Funk RS, Brown JT, and Abdel-Rahman SM (2012) Pediatric pharmacokinetics: human development and drug disposition. Pediatr Clin North Am 59:1001-1016.
18. Ghazalpour A, Bennett B, Petyuk VA, Orozco L, Hagopian R, Mungrue IN, Farber CR, Sinsheimer J, Kang HM, and Furlotte N, et al. (2011) Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet 7:e1001393.
19. Glatt H (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129: 141-170.
20. Hempel N, Gamage N, Martin JL, and McManus ME (2007) Human cytosolic sulfotransferase SULT1A1. Int J Biochem Cell Biol 39:685-689.
21. Henderson CJ and Wolf CR (2011) Knockout and transgenic mice in glutathione transferase research. Drug Metab Rev 43:152-164.
22. Hines RN (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250-267.
23. Huang J, Bathena SP, Tong J, Roth M, Hagenbuch B, and Alnouti Y (2010) Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1). Xenobiotica 40:184-194.
24. Ilic Z, Crawford D, Vakharia D, Egner PA, and Sell S (2010) Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1. Toxicol Appl Pharmacol 242:241-246.
25. Jakobsson PJ, Mancini JA, Riendeau D, and Ford-Hutchinson AW (1997) Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. J Biol Chem 272:22934-22939.
26. Jancova P, Anzenbacher P, and Anzenbacherova E (2010) Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154:103-116.
27. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, and Chowdhury NR (2000) Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 16:297-306.
28. Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, Roh JH, Do IG, Joh JW, and Kim DS (2009) Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J Exp Clin Cancer Res 28:20.
29. Klaassen CD and Slitt AL (2005) Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 6:309-328.
30. Knight TR, Choudhuri S, and Klaassen CD (2007) Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol Sci 100:513-524.
31. Krishna DR and Klotz U (1994) Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 26:144-160.
32. Lim CE, Matthaei KI, Blackburn AC, Davis RP, Dahlstrom JE, Koina ME, Anders MW, and Board PG (2004) Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol 165:679-693.
33. Lopez MF, Dikkes P, Zurakowski D, Villa-Komaroff L, and Majzoub JA (1999) Regulation of hepatic glycogen in the insulin-like growth factor II-deficient mouse. Endocrinology 140: 1442-1448.
34. Lu H, Cui JY, Gunewardena S, Yoo B, Zhong XB, and Klaassen CD (2012) Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing. Epigenetics 7:914-929.
35. MacKenzie PI, Rogers A, Elliot DJ, Chau N, Hulin JA, Miners JO, and Meech R (2011) The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. Mol Pharmacol 79:472-478.
36. Mackenzie PI, Rogers A, Treloar J, Jorgensen BR, Miners JO, and Meech R (2008) Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. J Biol Chem 283: 36205-36210.
37. Malone JH and Oliver B (2011) Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol 9:34.
38. Mladosievicova B, Dzurenkova A, Sufliarska S, and Carter A (2011) Clinical relevance of thiopurine S-methyltransferase gene polymorphisms. Neoplasma 58:277-282.
39. Monks TJ, Anders MW, Dekant W, Stevens JL, Lau SS, and van Bladeren PJ (1990) Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol 106:1-19.
40. Peng L, Yoo B, Gunewardena SS, Lu H, Klaassen CD, and Zhong XB (2012) RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development. Drug Metab Dispos 40:1198-1209.
41. Regan SL, Maggs JL, Hammond TG, Lambert C, Williams DP, and Park BK (2010) Acyl glucuronides: the good, the bad and the ugly. Biopharm Drug Dispos 31:367-395.
42. Saeki Y, Sakakibara Y, Araki Y, Yanagisawa K, Suiko M, Nakajima H, and Liu MC (1998) Molecular cloning, expression, and characterization of a novel mouse liver SULT1B1 sulfotransferase. J Biochem 124:55-64.
43. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, and Selbach M (2011) Global quantification of mammalian gene expression control. Nature 473:337-342.
44. Shimada M, Terazawa R, Kamiyama Y, Honma W, Nagata K, and Yamazoe Y (2004) Unique properties of a renal sulfotransferase, St1d1, in dopamine metabolism. J Pharmacol Exp Ther 310:808-814.
45. Sim E, Walters K, and Boukouvala S (2008) Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev 40:479-510.
46. Sumi D and Himeno S (2012) Role of arsenic (+3 oxidation state) methyltransferase in arsenic metabolism and toxicity. Biol Pharm Bull 35:1870-1875.
47. Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, Toutain PL, Laffont CM, and VandeVoort CA (2011) Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect 119:422-430.
48. Veiga-da-Cunha M, Tyteca D, Stroobant V, Courtoy PJ, Opperdoes FR, and Van Schaftingen E (2010) Molecular identification of NAT8 as the enzyme that acetylates cysteine S-conjugates to mercapturic acids. J Biol Chem 285:18888-18898.
49. Waxman DJ and Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215-228.
50. Zalko D, Soto AM, Dolo L, Dorio C, Rathahao E, Debrauwer L, Faure R, and Cravedi JP (2003) Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect 111: 309-319.
51. Zhu BT (2002) Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 3:321-349.